Skip to main content
Retour
HCA logo

HCA Healthcare, Inc.

Qualité des données : 100%
HCA
NYSE Healthcare Medical - Care Facilities
485,72 €
▼ 8,86 € (-1,79%)
Cap. Boursière : 108,62B
Fourchette du Jour
474,91 € 493,22 €
Fourchette 52 Semaines
314,43 € 556,52 €
Volume
1 154 116
Moyenne 50J / 200J
508,95 € / 443,17 €
Clôture Précédente
494,58 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (627 pairs)

Métrique Action Médiane du Secteur
P/E 16,0 0,3
P/B 2,9
ROE % 3,7
Net Margin % 9,0 3,8
Rev Growth 5Y % 6,5 10,0
D/E 0,2

Objectif de Cours des Analystes

Hold
523,92 € +7.9%
Low: 425,00 € High: 635,00 €
P/E Prévisionnel
16,3
BPA Prévisionnel
30,27 €
Croissance BPA (est.)
+0,0%
CA Est.
79 B

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2030 49,36 €
48,21 € – 50,93 €
100 B 5
FY2029 42,58 €
41,58 € – 43,93 €
93 B 2
FY2028 37,30 €
35,61 € – 38,71 €
87 B 7

Insider Trading Activity

Buy ratio (90d) 0.0%
20 transactions
Date Insider Type Shares Price Value
Feb 11, 2026
Berres Jennifer
SVP & Chief Human Res. Officer
sell 8 020 503,00 € 4 126 950 €
Feb 10, 2026
Berres Jennifer
SVP & Chief Human Res. Officer
grant 7 116
Feb 10, 2026
Berres Jennifer
SVP & Chief Human Res. Officer
other 2 515 502,05 € 1 262 656 €
Feb 6, 2026
Elcan Patricia F
other 73 186 329
Feb 6, 2026
FRIST THOMAS F III
other 73 186 329
Feb 6, 2026
Frist William R
other 73 186 329
Feb 6, 2026
HERCULES HOLDING II
other 36 629 188
Feb 6, 2026
Frisco Holding II
other 73 186 329
Feb 6, 2026
FRIST THOMAS F JR
other 73 186 329
Feb 4, 2026
HAZEN SAMUEL N
CEO
other 2 090 498,35 € 1 041 552 €
Feb 3, 2026
HAZEN SAMUEL N
CEO
sell 42 877 502,95 € 21 483 275 €
Jan 29, 2026
Marks Mike A
EVP and CFO
grant 11 945
Jan 29, 2026
McAlevey Michael R
EVP & Chief Legal & Admin Off.
grant 8 067
Oct 31, 2025
HAZEN SAMUEL N
CEO
other 144 273 69,58 €
May 13, 2025
Foster Jon M
EVP and COO
sell 15 698 369,32 € 5 797 661 €
May 13, 2025
Foster Jon M
EVP and COO
other 38 160
Apr 30, 2025
Frist William R
other 10 505 340,60 € 3 578 003 €
Apr 29, 2025
Frist William R
grant 1 026
Apr 29, 2025
FRIST THOMAS F III
grant 1 320
Apr 29, 2025
Dennis Robert J
grant 1 026

Points Clés

Revenue grew 6,51% annually over 5 years — modest growth
Earnings grew 17,78% over the past year
Generating 7,69B in free cash flow
PEG of 0,56 suggests growth is underpriced
Cash machine — converts 113,38% of earnings into free cash flow
Capital efficient — spends only 6,54% of revenue on capex

Croissance

Revenue Growth (5Y)
6,51%
Revenue (1Y)7,08%
Earnings (1Y)17,78%
FCF Growth (3Y)28,11%

Qualité

Return on Equity
N/A
ROIC20,32%
Net Margin8,97%
Op. Margin15,83%

Sécurité

Debt / Equity
N/A
Current Ratio0,83
Interest Coverage5,32

Valorisation

P/E Ratio
16,01
P/B RatioN/A
EV/EBITDA13,19
Dividend Yield0,01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 7,08% Revenue Growth (3Y) 7,87%
Earnings Growth (1Y) 17,78% Earnings Growth (3Y) 13,76%
Revenue Growth (5Y) 6,51% Earnings Growth (5Y) -0,62%
Profitability
Revenue (TTM) 75,60B Net Income (TTM) 6,78B
ROE N/A ROA 11,17%
Gross Margin 41,50% Operating Margin 15,83%
Net Margin 8,97% Free Cash Flow (TTM) 7,69B
ROIC 20,32% FCF Growth (3Y) 28,11%
Safety
Debt / Equity N/A Current Ratio 0,83
Interest Coverage 5,32 Dividend Yield 0,01%
Valuation
P/E Ratio 16,01 P/B Ratio N/A
P/S Ratio 1,44 PEG Ratio 0,56
EV/EBITDA 13,19 Dividend Yield 0,01%
Market Cap 108,62B Enterprise Value 157,78B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 75,60B 70,60B 64,97B 60,23B 58,75B
Net Income 6,78B 5,76B 5,24B 5,64B 6,96B
EPS (Diluted) 28,38 22,00 18,96 19,15 21,16
Gross Profit 31,37B 28,68B 25,58B 23,18B 22,49B
Operating Income 11,97B 10,55B 9,63B 9,05B 9,68B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 60,72B 59,51B 56,21B 52,44B 50,74B
Total Liabilities 63,49B 58,96B 55,15B 52,51B 49,25B
Shareholders' Equity -6,03B -2,50B -1,77B -2,77B -933,00M
Total Debt 50,20B 45,24B 41,86B 40,20B 36,73B
Cash & Equivalents 1,04B 1,93B 935,00M 908,00M 1,45B
Current Assets 13,56B 16,41B 14,93B 13,64B 13,54B
Current Liabilities 16,35B 15,18B 12,66B 9,90B 9,58B

Scores de Stratégies

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#228 of 332
43

Activité Récente

Entré Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026